Rose Perri
Chief Executive Officer bei EASTGATE BIOTECH CORP.
Profil
Rose C.
Perri has a career history that includes founding positions, current jobs, and education history.
Founding Positions:- Ms. Perri is the founder of Silvio Ventures, Inc. (founded in 1990).
-.
Ms. Perri is the founder of Generex Biotechnology Corp.
(founded in 1995).
Current Job:- Ms. Perri is currently the Chief Executive Officer & Director at Eastgate Biotech Corp.
(since 2015).
Education History:- Ms. Perri attended York University for undergraduate studies.
-.
Ms. Perri also attended the University of Toronto for undergraduate studies.
Aktive Positionen von Rose Perri
| Unternehmen | Position | Beginn |
|---|---|---|
| EASTGATE BIOTECH CORP. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Rose Perri
| Unternehmen | Position | Ende |
|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Founder | 01.05.2012 |
| Silvio Ventures, Inc. | Founder | - |
Ausbildung von Rose Perri
| York University | Undergraduate Degree |
| University of Toronto | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EASTGATE BIOTECH CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
| Silvio Ventures, Inc. | Finance |
